Prognia
Drug Database
🇪🇺EU · EMAWithdrawnATC: J07BB02

IDflu(influenza virus (inactivated, split) of the following strains:A/California/7/2009 (H1N1)pdm09 - like strain (A/California/7/2009, NYMC X-179A)A/Hong Kong/4801/2014 (H3N2) - like strain (A/Hong Kong/4801/2014, NYMC X-263B)B/Brisbane/60/2008 - like strain (B/Brisbane/60/2008, wild type))

Influenza, Human;Immunization

Marketing Authorisation Holder: Sanofi Pasteur S.A.

EMA Authorisation: 24/02/2009

INN: influenza vaccine (split virion, inactivated)

Indication

Prophylaxis of influenza in individuals 60 years of age and over, especially in those who run an increased risk of associated complications.The use of IDflu should be based on official recommendations.

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about IDflu — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Ask about IDfluCreate Free Account

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.